Strategic Consulting and Advisory Services
Certara is the largest and most comprehensive provider of biosimulation (modeling and simulation), strategic pharmacometrics, and regulatory writing consulting services. Our multidisciplinary team works alongside clients to inform key drug development decisions and expedite the processes around achieving regulatory milestones.
Software Portfolio: 'End-to-end' Modeling
Certara biosimulation (model based drug development and informatics) software portfolio is the most wide-ranging in the industry. Certara technology is relied upon by over 1,500 biopharm companies and academic institutions for drug research and development.
Certara's Programmatic Consulting Approach Delivers Unquestionable Value to Sponsor Companies
Certara combines its industry renowned pharmacometric and regulatory consultants with our vast software portfolio to provide services that focus on specific outcomes, therapeutic areas, regulatory milestones, and specific populations.
Leading Edge Science: Resource Library
Check out the latest brochures, case studies, white papers, webinars, and more! Search by keywords and/or filter results.
Press Releases
Certara Signs Partnership Agreement with ChemAxon
March 18, 2013
Certara signs partnership agreement with ChemAxon; Certara’s D360 to offer access to ChemAxon’s MarvinSketch and JChem Cartridge for Oracle.
Certara Releases Version 7.0 of D360
February 27, 2013
Certara releases D360 version 7.0, adds important user desired features to support enhanced scientific data access and analysis for pharma and biotech R&D.
Certara Supports Eleven Recent Drug Approvals through Model-Based Drug Development
February 13, 2013
Certara Supports Eleven Recent Drug Approvals through Model-Based Drug Development
Certara Establishes KSU College of Veterinary Medicine as Latest Phoenix Center of Excellence
February 05, 2013
Certara Establishes the Kansas State University College of Veterinary Medicine as the Latest Phoenix Center of Excellence
Certara Signs Partnership Agreement with Thomson Reuters
January 15, 2013
Certara and Thomson Reuters have signed a partnership agreement, focused on providing seamless access to data in Thomson Reuter’s Cortellis™ via Certara’s D360™.
Certara Supports PK/PD Training Program in China
December 13, 2012
Certara provides Phoenix Software for program offered by the Chinese Ministry of Education, to train Chinese students to apply PK/PD modeling and simulation to improve decision making in drug development, by simulating PK/PD outcomes before testing in animals or patients.
Plexxikon Selects Certara’s D360 for Scientific Data Access and Analysis
December 05, 2012
Plexxikon selects D360 for scientific data access, data mining, and analysis; enables researchers to easily query and analyze biological assay and chemical registration data from a single dashboard.
Certara Expands Senior Scientific Team
September 06, 2012
Christine E. Garnett joins Certara senior management team, leads development of next-generation cardiac safety modeling tools, works closely with global consulting services team on predictive modeling engagements to assess the cardiac proarrhythmic risk of new drug candidates.
Top 5 Pharma Licenses PKS Online as Global PK/PD Data Management System
July 19, 2012
Top 5 Pharma licenses PKS Online as their global PK/PD data management system, using hosted software to support compliant PK/PD analysis workflows.
U of Maryland School of Pharmacy’s Center for Translational Medicine Named Center of Excelllence
June 25, 2012
Certara Names University of Maryland School of Pharmacy’s Center for Translational Medicine as newest Phoenix® Center of Excellence; Collaboration Focused on Training the Next Generation of Pharmacometric Leaders.
Certara Releases Major Advance to Phoenix Software Platform
April 10, 2012
Certara releases Phoenix version 1.3, adds new population PK/PD modeling algorithm, 64-bit support and many usability enhancements to support model-based-drug development.
Certara Announces Completion of Acquisition of Simcyp Limited
March 13, 2012
Certara™, a Vector Capital portfolio company and a leading provider of drug discovery and development software and scientific consulting services, today announced the completion of its acquisition of UK-based Simcyp Limited.
Certara Announces Acquisition Agreement with Simcyp Limited
February 24, 2012
Certara™, a leading provider of drug discovery and development software and scientific consulting services and a Vector portfolio company, today announced agreement to acquire Simcyp Limited.
Certara’s D360 Selected for Enterprise Wide Safety Analysis
January 17, 2012
Certara™, a leading provider of software and services to improve productivity and decision-making from discovery through clinical development, announced today that a Top 10 pharma Company, after completing an extensive competitive review process, has selected D360 as its enterprise solution for conducting single-study and cross-study search and analysis of preclinical safety data.
Certara Releases D360 Version 6.0, with Extended Capabilities for Preclinical and Clinical Data
December 20, 2011
Certara™, a leading provider of software and services to improve productivity and decision-making from discovery through clinical development, announced today that it has released D360™ version 6.0, with key enhancements that enable users to access data from clinical and preclinical data sources in addition to discovery.
Certara to Distribute Leading Software for Predicting Off-Target Effects of Small Molecules
October 05, 2011
Certara™, a leading provider of software and services to improve productivity and decision-making from drug discovery through clinical development, announced that it will be the exclusive provider of Chemotargets software for predicting the off-target pharmacology of small molecules.
D360 Licensed by Top 15 Global Pharmaceutical Company for Data Integration and Data Mining
July 12, 2011
Certara™, a leading provider of software and services to improve productivity and decision-making from drug discovery through clinical development, today announced that a top 15 global pharmaceutical company has licensed D360 as its enterprise solution for scientific data integration and data mining, visualization, and analysis.